Restricted accessOtherFirst published online 2001-4
Questions and Answers from the F.I.X./• Heparin Alternatives for Central Lines/• Bulk Albuterol Solution/• NAEPP Guidelines for the Use of Palm OS Devices/• Trimethoprim/Sulfamethoxazole and Hyponatremia/• Esmolol IV Infusion Guidelines/• Fentanyl Alternatives in Infants and Children/• H 2 Blockers and Immunosuppression
The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers of The Formulary Monograph Service or you may log on through drugfacts.com. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X.
Get full access to this article
View all access options for this article.
References
1.
a. Pediatric Dosage Handbook 1999–2000, ed. 6.
2.
b. MeistelmanC., MauriceC., LepaulM.A comparison of alfentanil pharmacokinetics in children and adults. Anesthesiology.1987; 66(1): 13–16.
3.
c. SanteiroM., ChristieJ., StromquistC.Pharmacokinetics of continuous infusion fentanyl in newborns. J Perinatol.1997; 17(2): 135–39.
4.
d. GuayJ., GaudreaultP., TangA.Pharmacokinetics of sufentanil in normal children. Can J Anaesth.1992; 39(1): 14–20.
5.
e. Jacqz-AigrainE., BurtinP.Clinical pharmacokinetics of sedatives in neonates. Clin Pharmacokinet.1996; 31(6): 423–43.
6.
f. RoureP., JeanN., LeclercA.Pharmacokinetics of alfentanil in children undergoing surgery. Br J Anaesth.1987; 59(11): 1437–40.
7.
g. MeistelmanC., BenhamouD., BarreJ.Effects of age on plasma protein binding of sufentanil. Anesthesiology.1990; 72(3): 470–3.
